548-19-6 Usage
Description
Isoginkgetin is a biflavonoid found in G. biloba, which acts as an inhibitor of pre-mRNA splicing. It has been shown to reduce mRNA activity, shift the composition of total RNA extract, arrest cell growth, suppress lymphocyte proliferation, and decrease matrix metalloproteinase-9 (MMP-9) activity and expression.
Uses
Used in Pharmaceutical Industry:
Isoginkgetin is used as a potential therapeutic agent for various applications due to its inhibitory effects on pre-mRNA splicing, cell growth arrest, lymphocyte proliferation suppression, and MMP-9 reduction.
Used in Research Applications:
Isoginkgetin is used as a research tool for studying the effects of pre-mRNA splicing inhibition on cell growth and function, as well as its potential role in modulating immune responses and MMP-9 activity.
Check Digit Verification of cas no
The CAS Registry Mumber 548-19-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,4 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 548-19:
(5*5)+(4*4)+(3*8)+(2*1)+(1*9)=76
76 % 10 = 6
So 548-19-6 is a valid CAS Registry Number.
InChI:InChI=1/C32H22O10/c1-39-18-6-3-15(4-7-18)26-14-24(38)31-22(36)12-21(35)29(32(31)42-26)19-9-16(5-8-25(19)40-2)27-13-23(37)30-20(34)10-17(33)11-28(30)41-27/h3-14,33-36H,1-2H3
548-19-6Relevant articles and documents
Biological Investigation of a Water-Soluble Isoginkgetin-Phosphate Analogue, Targeting the Spliceosome with In Vivo Antitumor Activity
Letribot, Boris,Nascimento, Megane,Cerrato, Giulia,Darrigrand, Romain,Salgues, Valerie,Renko, Dolor,Pruvost, Alain,Alami, Mouad,Messaoudi, Samir,Apcher, Sebastien
, p. 4633 - 4648 (2022/03/27)
The first total synthesis of the natural product Isoginkgetin as well as four water-soluble Isoginkgetin-phosphate analogues is reported herein. Moreover, the full study of the IP2 phosphate analogue with respect to pharmacological properties (metabolic and plasmatic stabilities, pharmacokinetic, off-target, etc.) as well as in vitro and in vivo biological activities are disclosed herein.